Quantum Biopharma (QNTM) Amortization - Intangibles (2024 - 2026)

Quantum Biopharma has disclosed Amortization - Intangibles across 3 years of filings, most recently posting $13267.0 for Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $13267.0, down 95.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $473831.0 (up 38.14% YoY), and the FY2024 annual result was $14560.0, changed N/A from the prior year.
• Amortization - Intangibles came in at $13267.0 for Q1 2026 at Quantum Biopharma, down from $13505.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $328448.0 in Q1 2025 to a low of $13267.0 in Q1 2026.
• The 3-year median for Amortization - Intangibles is $14560.0 (2024), against an average of $97678.2.
• Peak annual rise in Amortization - Intangibles reached 95.96% in 2026, while the deepest fall reached 95.96% in 2026.
• Quantum Biopharma's Amortization - Intangibles stood at $14560.0 in 2024, then declined by 7.25% to $13505.0 in 2025, then dropped by 1.76% to $13267.0 in 2026.
• The last three Amortization - Intangibles figures came in at $13267.0 (Q1 2026), $13505.0 (Q3 2025), and $118611.0 (Q2 2025), per Business Quant data.